Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bronstein, Gewirtz & Grossman, Llc
Bronstein, Gewirtz & Grossman, LLC Announces That a Class Action has Been Filed Against Fidelity Ultra-Short Bond Fund
July 27th, 2008
Bronstein, Gewirtz & Grossman, LLC announces that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of purchasers of the Fidelity Ultra-Short Bond Fund (the "Fund") (NASDAQ:FUSFX) who purchased the fund between June 6, 2005 and June 5, 2008 (the "Class Period"). The complaint charges Fidelity Management & Research Company, among others (the "Defendants"), with violations of the Securities Act of 1933. The complaint alleges that on or about August 23, 2002, the Defendants began offering shares of the Ultra-Short Bond Fund pursuant to an initial registration statement, filed with the SEC as a Form 485BPOS...
Source: Pharma Investments, Ventures & Law Weekly (2008-07-27)
|
